RHJA
NRC icon

Rice Hall James & Associates’s NRC Health Common Stock NRC Stock Holding History

Rice Hall James & Associates’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,205
Closed -$567K – 304
2017
Q4 		$567K Buy
15,205
+164
+1% +$5.82K 0.02% 271
2017
Q3 		$567K Buy
15,041
+6
+0% +$188 0.03% 257
2017
Q2 		$404K Buy
15,035
+155
+1% +$3.79K 0.02% 266
2017
Q1 		$293K Buy
14,880
+400
+3% +$7.4K 0.01% 283
2016
Q4 		$275K Buy
14,480
+2,448
+20% +$40.4K 0.01% 279
2016
Q3 		$196K Buy
12,032
+134
+1% +$2.1K 0.01% 292
2016
Q2 		$163K Sell
11,898
-90
-0.8% -$1.27K 0.01% 293
2016
Q1 		$186K Sell
11,988
-185
-2% -$2.71K 0.01% 289
2015
Q4 		$195K Buy
12,173
+345
+3% +$5.24K 0.01% 297
2015
Q3 		$141K Sell
11,828
-544
-4% -$7.22K 0.01% 297
2015
Q2 		$176K Sell
12,372
-1,302
-10% -$18.4K 0.01% 305
2015
Q1 		$197K Buy
+13,674
New +$193K 0.01% 309

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Spitfire Capital Mill Valley, California $77.1M AUM 13.16% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rice Hall James & Associates's NRC Position: Q1 2018 in Review

Rice Hall James & Associates sold out of NRC Health Common Stock (NRC) in Q1 2018, closing a stake of 15,205 shares — an estimated $567K sold.

Rice Hall James & Associates first reported a position in NRC in Q1 2015 and held it in 12 quarters. The position peaked at $567K in Q4 2017. 74 funds tracked by Wall St. Rank hold NRC as of Q1 2018.

  • Rice Hall James & Associates reported no remaining NRC Health Common Stock position as of Q1 2018 after selling out during the quarter.
  • Rice Hall James & Associates sold 15,205 NRC Health Common Stock shares in Q1 2018, an estimated $567K.
  • Rice Hall James & Associates first reported a position in NRC Health Common Stock in Q1 2015 and held it in 12 quarters.
  • Rice Hall James & Associates's NRC Health Common Stock position peaked at $567K in Q4 2017.
  • 74 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2018.

Based on Rice Hall James & Associates's 13F filing for Q1 2018, filed 25 Apr 2018.